Corgentech to start E2F Decoy Phase III

Corgentech (Palo Alto, Calif.) said it will begin U.S. Phase III testing of its E2F Decoy solution in 1,400 patients undergoing peripheral bypass surgery for leg pain at rest, non-healing ulceration o...